AbbVie (ABBV) Tops Q3 EPS by 7c, Raises FY Guidance

October 30, 2020 7:48 AM

AbbVie (NYSE: ABBV) reported Q3 EPS of $2.83, $0.07 better than the analyst estimate of $2.76. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $12.72 billion.


AbbVie sees FY2020 EPS of $10.47-$10.49, versus the consensus of $10.72.

For earnings history and earnings-related data on AbbVie (ABBV) click here.


Earnings Guidance

Next Articles